Matches in DBpedia 2016-04 for { ?s ?p "High-altitude cerebral edema (HACE) is a medical condition in which the brain swells with fluid because of the physiological effects of traveling to a high altitude. It generally appears in patients who have acute mountain sickness and involves disorientation, lethargy, and nausea among other symptoms. It occurs when the body fails to acclimatize while ascending to a high altitude. It appears to be a vasogenic edema, fluid penetration of the blood–brain barrier, although cytotoxic edema, cellular retention of fluids, may play a role as well. Individuals with the condition must immediately descend to a lower altitude or coma and death can occur. Patients are usually given supplemental oxygen and dexamethasone as well. HACE can be prevented by ascending to heights slowly to allow the body more time to acclimatize. Acetazolamide also helps prevent the condition. If untreated, patients usually die within 48 hours, and those who receive treatment often take days or weeks to fully recover. It is a rare condition, occurring in less than one percent of people who ascend to 4,000 metres (13,000 ft). First described in 1913, little was known about the etiology of the condition until MRI studies were performed in the 1990s."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- High-altitude_cerebral_edema abstract "High-altitude cerebral edema (HACE) is a medical condition in which the brain swells with fluid because of the physiological effects of traveling to a high altitude. It generally appears in patients who have acute mountain sickness and involves disorientation, lethargy, and nausea among other symptoms. It occurs when the body fails to acclimatize while ascending to a high altitude. It appears to be a vasogenic edema, fluid penetration of the blood–brain barrier, although cytotoxic edema, cellular retention of fluids, may play a role as well. Individuals with the condition must immediately descend to a lower altitude or coma and death can occur. Patients are usually given supplemental oxygen and dexamethasone as well. HACE can be prevented by ascending to heights slowly to allow the body more time to acclimatize. Acetazolamide also helps prevent the condition. If untreated, patients usually die within 48 hours, and those who receive treatment often take days or weeks to fully recover. It is a rare condition, occurring in less than one percent of people who ascend to 4,000 metres (13,000 ft). First described in 1913, little was known about the etiology of the condition until MRI studies were performed in the 1990s.".
- Q1643608 abstract "High-altitude cerebral edema (HACE) is a medical condition in which the brain swells with fluid because of the physiological effects of traveling to a high altitude. It generally appears in patients who have acute mountain sickness and involves disorientation, lethargy, and nausea among other symptoms. It occurs when the body fails to acclimatize while ascending to a high altitude. It appears to be a vasogenic edema, fluid penetration of the blood–brain barrier, although cytotoxic edema, cellular retention of fluids, may play a role as well. Individuals with the condition must immediately descend to a lower altitude or coma and death can occur. Patients are usually given supplemental oxygen and dexamethasone as well. HACE can be prevented by ascending to heights slowly to allow the body more time to acclimatize. Acetazolamide also helps prevent the condition. If untreated, patients usually die within 48 hours, and those who receive treatment often take days or weeks to fully recover. It is a rare condition, occurring in less than one percent of people who ascend to 4,000 metres (13,000 ft). First described in 1913, little was known about the etiology of the condition until MRI studies were performed in the 1990s.".